Cureworth Drugs & Intermediates Private Limited - Company Profile

It is a pharma private limited company based in Panvel, Maharashtra, India, established in 2010.
2010 Panvel, Maharashtra, India Active
Last Updated:
Access Report
About Cureworth Drugs & Intermediates Private Limited

Cureworth Drugs & Intermediates Private Limited, a active private limited company, was established on 14 June 2010 in Panvel, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24232MH2010PTC204157. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹4.00 M.

It upholds a compliant status. Employing 39 professional, Its leadership includes Anjana Ramchadra Nishad (Director), Ramchandra Rambrish Nishad (Director). Past directors included Anjana Ramchadra Nishad, Swati Vasudev Sahani, Ashutosh Suresh Gokhale. It holds ₹12.88 Cr open charges and ₹23.89 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. G-48, 2Nd Floor, Anjani Niwas,, Sector No. 12, Kharghar, Panvel, Maharashtra, 410210.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MH2010PTC204157

  • Registration Number

    204157

  • Incorporation Date

    14 June 2010

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹4.00 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 4.00 M
  • Company Age 15 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 12.88 Cr
  • Satisfied Charges ₹ 23.89 Cr
  • Revenue Growth **** -41.68%
  • Profit Growth **** -69.03%
  • Ebitda **** -45.71%
  • Net Worth 6.23%
  • Total Assets -4.88%
Company report

Cureworth Drugs & Intermediates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cureworth Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cureworth Drugs & Intermediates Private Limited?
Current Directors
Name Designation Appointment Date Status
Anjana Ramchadra Nishad Director 15 Jun 2010 Current
Ramchandra Rambrish Nishad Director 14 Jun 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2011 Past
Pramod Abcsdd Director 31 Mar 2023 Past
Pramod Abcsdd Director 01 Apr 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cureworth Drugs & Intermediates.

Cureworth Drugs & Intermediates Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.68% decrease. The company also saw a substantial fall in profitability, with a 69.03% decrease in profit. The company's net worth moved up by a moderate rise of 6.23%.

Cureworth Drugs & Intermediates revenue growth over time
Cureworth Drugs & Intermediates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -41.68%
*******
*******
*******
*******
Revenue from Operations
*******
 -41.95%
*******
*******
*******
*******
Total Assets
*******
 -4.88%
*******
*******
*******
*******
Profit or Loss
*******
 -69.03%
*******
*******
*******
*******
Net Worth
*******
 6.23%
*******
*******
*******
*******
EBITDA
*******
 -45.71%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cureworth Drugs & Intermediates?

In 2022, Cureworth Drugs & Intermediates had a public holding of 6.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹128,800,000.00

Satisfied Charges

₹238,927,000.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 12.88 Cr
Latest Charge Details
Date Lender Amount Status
15 Feb 2025 Bank Of India ₹12.88 Cr Open
27 Mar 2023 Hdfc Bank Limited ₹6.45 Cr Satisfied
24 Mar 2023 Hdfc Bank Limited ₹6.60 Cr Satisfied
28 Jun 2021 Bank Of India ₹2.50 Cr Satisfied
07 Apr 2021 Bank Of India ₹2.40 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cureworth Drugs & Intermediates?

Cureworth Drugs & Intermediates has a workforce of 39 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cureworth Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureworth Drugs & Intermediates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cureworth Drugs & Intermediates
Recent Activity within the Organization
  • Annual General Meeting

    The activity Cureworth Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Bank Of India of Rs. 128.80 M registered on 15 Feb 2025 with Charge ID 101069095 was modified on 21 Apr 2025. was documented.

  • Charges

    The activity A charge registered on 27 Mar 2023 via Charge ID 100802455 with Hdfc Bank Limited was fully satisfied on 31 Mar 2025. was completed.

  • Charges

    A charge registered on 24 Mar 2023 via Charge ID 100745571 with Hdfc Bank Limited was fully satisfied on 31 Mar 2025. was recorded as a recent event.

  • Balance Sheet

    Progress on Cureworth Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 128.80 M with Charge ID 101069095 was registered on 15 Feb 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cureworth Drugs & Intermediates Private Limited?

The CIN of Cureworth Drugs & Intermediates Private Limited is U24232MH2010PTC204157.

Where is Cureworth Drugs & Intermediates Private Limited headquartered?

Cureworth Drugs & Intermediates Private Limited is headquartered at Plot No. G-48, 2Nd Floor, Anjani Niwas,, Sector No. 12, Kharghar, Panvel, Maharashtra, 410210.

When was Cureworth Drugs & Intermediates Private Limited incorporated?

Cureworth Drugs & Intermediates Private Limited was incorporated on 14 June 2010.

Who are the current directors of Cureworth Drugs & Intermediates Private Limited?

The current directors of Cureworth Drugs & Intermediates Private Limited are

What is the primary industry of Cureworth Drugs & Intermediates Private Limited?

The primary industry of Cureworth Drugs & Intermediates Private Limited is Manufacturing.

Is Cureworth Drugs & Intermediates Private Limited a listed company?

Cureworth Drugs & Intermediates Private Limited is unlisted.

What is the capital structure of Cureworth Drugs & Intermediates Private Limited?

The authorized capital of Cureworth Drugs & Intermediates Private Limited is ₹5.00 M, and the paid-up capital is ₹4.00 M.

What is the compliance status of Cureworth Drugs & Intermediates Private Limited?

The compliance status of Cureworth Drugs & Intermediates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available